Literature DB >> 19661083

Pregnancy outcomes among adult survivors of childhood cancer in the British Childhood Cancer Survivor Study.

Raoul C Reulen1, Maurice P Zeegers, W Hamish B Wallace, Clare Frobisher, Aliki J Taylor, Emma R Lancashire, Dave L Winter, Mike M Hawkins.   

Abstract

PURPOSE: We used data from the first large-scale overwhelmingly population-based study (a) to quantify the risk of adverse pregnancy outcomes in survivors of childhood cancer in relation to cancer type and treatment and (b) to assess live birth rates relative to the general population.
METHODS: A questionnaire, including questions inquiring about pregnancy outcomes, was completed by 10,483 survivors. A total of 7,300 pregnancies were reported. Odds ratios (OR) for live birth, miscarriage, termination, stillbirth, premature birth, and low birth weight were calculated for different types of childhood cancer and by whether initial treatment involved chemotherapy and abdominal or brain irradiation. For females, the observed number of live births was compared with that expected based on the general population of England and Wales.
RESULTS: Female survivors exposed to abdominal irradiation had a significantly increased OR of delivering preterm [OR, 3.2; 95% confidence interval (95% CI), 2.1-4.7] and producing offspring with a low birth weight (OR, 1.9; 95% CI, 1.1-3.2). An increased OR of miscarriage was also associated with abdominal radiotherapy (OR, 1.4; 95% CI, 1.0-1.9). The number of live births observed from all female survivors was two thirds of that expected (O/E, 0.64; 95% CI, 0.62-0.66) and lowest among survivors treated with brain (O/E, 0.52; 95% CI, 0.48-0.56) and abdominal radiotherapy (O/E, 0.55; 95% CI, 0.50-0.61).
CONCLUSION: Female survivors of childhood cancer treated with abdominal radiotherapy are at 3-fold increased risk of delivering preterm, 2-fold increased risk of low birth weight, and a small increased risk of miscarriage. Overall, female survivors produce considerably fewer offspring than expected, particularly those treated with abdominal or brain radiotherapy.

Entities:  

Mesh:

Year:  2009        PMID: 19661083      PMCID: PMC2730581          DOI: 10.1158/1055-9965.EPI-09-0287

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  36 in total

1.  Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound.

Authors:  L E Bath; W H B Wallace; M P Shaw; C Fitzpatrick; R A Anderson
Journal:  Hum Reprod       Date:  2003-11       Impact factor: 6.918

2.  Ultrasound B-mode changes in the uterus and ovaries and Doppler changes in the uterus after total body irradiation and allogeneic bone marrow transplantation in childhood.

Authors:  K Holm; K Nysom; V Brocks; H Hertz; N Jacobsen; J Müller
Journal:  Bone Marrow Transplant       Date:  1999-02       Impact factor: 5.483

3.  Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964-1988 in Ontario, Canada.

Authors:  A M Chiarelli; L D Marrett; G Darlington
Journal:  Am J Epidemiol       Date:  1999-08-01       Impact factor: 4.897

4.  Hypothalamic-pituitary-ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia.

Authors:  L E Bath; R A Anderson; H O Critchley; C J Kelnar; W H Wallace
Journal:  Hum Reprod       Date:  2001-09       Impact factor: 6.918

5.  Pregnancy outcome after treatment for Wilms tumor: a report from the National Wilms Tumor Study Group.

Authors:  Daniel M Green; Eve M Peabody; Bin Nan; Susan Peterson; John A Kalapurakal; Norman E Breslow
Journal:  J Clin Oncol       Date:  2002-05-15       Impact factor: 44.544

6.  Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement.

Authors:  L E Bath; H O Critchley; S E Chambers; R A Anderson; C J Kelnar; W H Wallace
Journal:  Br J Obstet Gynaecol       Date:  1999-12

7.  Sonographic detection of uterine and ovarian abnormalities in female survivors of Wilms' tumor treated with radiotherapy.

Authors:  A R Nussbaum Blask; H S Nicholson; B M Markle; K Wechsler-Jentzch; R O'Donnell; J Byrne
Journal:  AJR Am J Roentgenol       Date:  1999-03       Impact factor: 3.959

8.  Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Authors:  Daniel M Green; John A Whitton; Marilyn Stovall; Ann C Mertens; Sarah S Donaldson; Frederick B Ruymann; Thomas W Pendergrass; Leslie L Robison
Journal:  Am J Obstet Gynecol       Date:  2002-10       Impact factor: 10.693

9.  Pregnancy outcome of partners of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Authors:  Daniel M Green; John A Whitton; Marilyn Stovall; Ann C Mertens; Sarah S Donaldson; Frederick B Ruymann; Thomas W Pendergrass; Leslie L Robison
Journal:  J Clin Oncol       Date:  2003-02-15       Impact factor: 50.717

10.  Marriage in the survivors of childhood cancer: a preliminary description from the Childhood Cancer Survivor Study.

Authors:  A M Rauck; D M Green; Y Yasui; A Mertens; L L Robison
Journal:  Med Pediatr Oncol       Date:  1999-07
View more
  46 in total

Review 1.  Fertility and pregnancy in cancer survivors.

Authors:  Monica Tang; Kate Webber
Journal:  Obstet Med       Date:  2018-03-29

2.  Life beyond the disease: relationships, parenting, and quality of life among survivors of childhood cancer.

Authors:  Andrew C Dietz; Daniel A Mulrooney
Journal:  Haematologica       Date:  2011-05       Impact factor: 9.941

3.  Chemotherapy-related damage to ovarian reserve in childhood cancer survivors: interpreting the evidence.

Authors:  Edgardo Somigliana; Monica Terenziani; Francesca Filippi; Alice Bergamini; Fabio Martinelli; Giorgia Mangili; Fedro Peccatori; Paolo Vercellini
Journal:  J Assist Reprod Genet       Date:  2018-10-25       Impact factor: 3.412

4.  Cohort Profile: the French childhood cancer survivor study for leukaemia (LEA Cohort).

Authors:  Julie Berbis; Gérard Michel; André Baruchel; Yves Bertrand; Pascal Chastagner; François Demeocq; Justyna Kanold; Guy Leverger; Dominique Plantaz; Marilyne Poirée; Jean-Louis Stephan; Pascal Auquier; Audrey Contet; Jean-Hugues Dalle; Stéphane Ducassou; Virginie Gandemer; Patrick Lutz; Nicolas Sirvent; Marie-Dominique Tabone; Sandrine Thouvenin-Doulet
Journal:  Int J Epidemiol       Date:  2014-03-17       Impact factor: 7.196

5.  Vaginal delivery after hemipelvectomy and pelvic radiotherapy for chondrosarcoma.

Authors:  J L Browne; M A Oudijk; H R Holtslag; H W R Schreuder
Journal:  BMJ Case Rep       Date:  2014-09-25

6.  Lifestyle, distress, and pregnancy outcomes in the Childhood Cancer Survivor Study cohort.

Authors:  Prasad L Gawade; Kevin C Oeffinger; Charles A Sklar; Daniel M Green; Kevin R Krull; Wassim Chemaitilly; Marilyn Stovall; Wendy Leisenring; Gregory T Armstrong; Leslie L Robison; Kirsten K Ness
Journal:  Am J Obstet Gynecol       Date:  2014-07-25       Impact factor: 8.661

7.  Young Adult Female Cancer Survivors' Concerns About Future Children's Health and Genetic Risk.

Authors:  Nirupa Jaya Raghunathan; Catherine Benedict; Bridgette Thom; Danielle Novetsky Friedman; Joanne Frankel Kelvin
Journal:  J Adolesc Young Adult Oncol       Date:  2018-01-24       Impact factor: 2.223

Review 8.  Pregnancy and child health outcomes in pediatric and young adult leukemia and lymphoma survivors: a systematic review.

Authors:  Ksenya Shliakhtsitsava; Sally A D Romero; Samantha Rose Dewald; H Irene Su
Journal:  Leuk Lymphoma       Date:  2017-07-21

Review 9.  Oncofertility: Meeting the Fertility Goals of Adolescents and Young Adults With Cancer.

Authors:  H Irene Su; Yuton Tony Lee; Ronald Barr
Journal:  Cancer J       Date:  2018 Nov/Dec       Impact factor: 3.360

10.  Preterm delivery among female survivors of childhood, adolescent and young adulthood cancer.

Authors:  Laura-Maria Madanat-Harjuoja; Nea Malila; Päivi M Lähteenmäki; John D Boice; Mika Gissler; Tadeusz Dyba
Journal:  Int J Cancer       Date:  2010-10-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.